Fungal infections in cancer patients

Michael Angarone1

  • 1Division of Infectious Disease, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave, Suite 900, Chicago, IL, 60611, USA, m-angarone@northwestern.edu.

Insights

Invasive fungal infections (IFI) pose significant risks to cancer patients, often presenting diagnostic and treatment challenges. Advances in noninvasive techniques and therapies are improving outcomes for these serious infections.

Area of Science:

  • Mycology
  • Oncology
  • Infectious Diseases

Background:

  • Invasive fungal infections (IFI) are a major cause of illness and death in cancer patients.
  • Diagnosing and treating IFIs can be complex due to pathogen variability and diagnostic challenges.

Purpose of the Study:

  • To highlight the challenges in diagnosing and treating invasive fungal infections in cancer patients.
  • To introduce advancements in diagnostic and therapeutic strategies for IFIs.

Main Methods:

  • Review of current diagnostic and treatment modalities for IFIs in oncology.
  • Discussion of emerging noninvasive diagnostic techniques.
  • Evaluation of newer, more effective antifungal treatments.

Main Results:

  • IFI diagnosis often requires invasive procedures and a high index of suspicion.
  • Pathogen identification can be difficult, impacting treatment selection.
  • Newer noninvasive diagnostic tools are becoming available.
  • Current treatments are better tolerated and more effective.

Conclusions:

  • Early and accurate diagnosis of IFIs is critical for cancer patient outcomes.
  • Advancements in diagnostics and therapeutics are improving the management of IFIs.
  • Continued research into noninvasive methods and novel treatments is essential.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K